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Incidence of the anterior resection syndrome 
using low anterior resection score (LARS scale)
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Background
Up to 90 % of patients undergoing low anterior resection, complain of increased daily bowel movements, urgency for def-
ecation, and a variable degree of incontinence. A symptom-based scoring system for bowel dysfunction after low anterior 
resection for rectal cancer has recently been validated in Lithuanian population. 
Purpose: we aimed to measure the incidence and severity of the anterior resection syndrome (ARS) using LARS and its cor-
relation with selected variables or risk factors.
Methods
LARS score was sent to 183 patients who underwent low anterior resection with TME with coloanal anastomosis from January 
1st, 2008 to December 31st, 2012 at the National Cancer Institute. Of them 111 (responsibility was 60.7%) have completed the 
questionnaire. The variables studied were age, sex, location of the tumour, neoadjuvant radiotherapy, time after treatment. 
Results
Of 111 questionnaires 108 were completed properly (59.0%). 27 patients (25%) had no ARS, 26 (24%) had minor ARS and 55 
(56%) had major ARS. In univariate analysis age, sex, neoadjuvant radiotherapy, and tumour localization did not have an im-
Originalūs mokslo tiriamieji darbai
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pact on severity of bowel dysfunction symptoms after low anterior resection with TME. Also there was no difference between 
female and male patient groups (p=0.33), patients who had/had not undergone radiation therapy (p=0.07), and those with 
low or high tumour edge level (p=0.17). However, time after operation (< 12 months) was associated to ARS.
Conclusion
More than half of the operated patients presented severe LARS score and only a one fourth did not provide a quantifiable 
ARS. Timing after surgery was the main factor affecting ARS. 
Key words: low anterior resection, low anterior resection syndrome, LARS score, total mesorectal excision
Įvadas
Iki 90 proc. pacientų, operuotų dėl tiesiosios žarnos navikų, skundžiasi padažnėjusio tuštinimosi epizodais, nesulaikomu noru 
tuštintis, įvairaus laipsnio išmatų nelaikymu. Visai neseniai tuštinimosi sutrikimų skalė šiems simptomams vertinti buvo iš-
versta į lietuvių kalbą ir patvirtinta naudoti klinikinėje praktikoje.  
Tyrimo tikslas
Mūsų tikslas buvo nustatyti porezekcinio tiesiosios žarnos sindromo (ARS) pasireiškimo dažnį ir sunkumą pacientams po tie-
siosios žarnos rezekcijos bei išsiaiškinti rizikos veiksnius. 
Metodai
Porezekcinio tiesiosios žarnos sindromo skalė buvo išsiųsta 183 pacientams, kuriems nuo 2008 m. sausio 1 d. iki 2012 m. 
gruodžio 31 d. Nacionaliniame vėžio institute buvo atlikta tiesiosios žarnos rezekcija su totaline mezorektaline ekscizija su-
formuojant žarnos jungtį. Iš jų skalę užpildė 111 (atsakomumas – 60,7 %). Kartu tyrėme šiuos galimus blogesnės tuštinimosi 
funkcijos rizikos veiksnius: lytis, amžius, naviko aukštis, priešoperacinis spindulinis gydymas, laikas po operacijos. 
Rezultatai
Iš 111 užpildytų klausimynų 108 buvo užpildyti tinkamai (59 %). 27 pacientams (25 %) ARS nepasireiškė, 26 (24 %) pasireiškė 
silpnas ARS, o net 55 (56 %) – ryškus. Išanalizavę rizikos veiksnius nustatėme, jog tik laikas po operacijos buvo lemiamas veiks-
nys ARS po operacijos pasireikšti (ilgesnis laikas, ne tokie ryškūs simptomai). 
Išvados
Daugiau nei pusei pacientų atsirado ryškus tuštinimosi sutrikimas ir tik ketvirtadalis neturėjo jokių skundų. Laikas, praėjęs 
nuo operacijos, buvo vienintelis teigiamas veiksnys šiems simptomams susilpnėti. 
Reikšminiai žodžiai: tiesiosios žarnos rezekcija, porezekcinis tiesiosios žarnos sindromas, porezekcinio tiesiosios žarnos sin-
dromo skalė, totalinė mezorektalinė ekscizija
the impaired capacity and compliance of the remnant 
of the rectum, and the loss of rectal sensation [1]. Fur-
thermore, urinary and sexual dysfunction may occur in 
10–35% of patients [4].
A symptom-based scoring system for bowel dysfunc-
tion after low anterior resection for rectal cancer has 
recently been developed and validated by Emmertsen 
[5]. Since then, the LARS score has been translated and 
validated in several languages, including Lithuanian 
language [6, 7].
The aim of this study was to study the incidence, 
distribution and severity of ARS among our rectal 
cancer patients treated by anterior resection using the 
LARS score. Also we aimed to confirm its quantitative 
correlation with the risk factors which are known to be 
connected with ARS.
Introduction
In the last 3 decades advances in rectal cancer treatment 
have achieved a reduction in the locoregional recurrence 
rate. During this period low anterior resection with to-
tal mesorectal excision (TME) became a gold standard 
for rectal cancer treatment. Most of the patients (up 
to 90%) operated with preservation of the sphincter 
will develop an alteration of intestinal and defecatory 
functions. The dysfunction varies in its symptoms and 
severity, and it manifests as urgency, incontinence and 
fragmented defecation, with bowel movements that 
are repeated, incomplete or difcult. The set of these 
symptoms constitutes what is known as the anterior 
resection syndrome (ARS) [1]. The syndrome is at-
tributed to rectal sphincter injury, denervation during 
pelvic dissection [2, 3], the low coloanal anastomosis, 
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Patients and methods
Patients
All of the patients treated in our hospital for rectal 
cancer with a curative purpose by anterior resection 
of the rectum from January 2008 to December 2012 
were included in this study. An Ileostomy takedown 
was performed on an average of 3 months following 
primary surgery. Patients were questioned at least 6 
months after the ileostomy takedown, from August to 
November, 2013. To all patients a letter by mail contain-
ing the request to take part in the study, an informative 
note describing its aim and a declaration of its confi-
dentiality was sent. It also contained the LARS scale 
questionnaire in Lithuanian. The patients who failed to 
answer the questionnaire appropriately were excluded. 
Questionnaires were sent to 183 patients. 111 (60.7%) 
of them, 69 males and 39 females, responded (mean age 
66.9 years). Three patients failed to complete the ques-
tionnaire. 108 (59.0%) fully completed questionnaires 
were the object of our final analysis. 
Patients with T3 (with any N stage) cancer or node-
positive T1 or T2 cancer, underwent short-course radio-
therapy prior to surgery (5x5Gy). Patients who had T3 
tumour with an endangered circumferential margin or 
T4 tumour (any N), underwent long-course radiother-
apy with two cycles of 5-FU based chemotherapy before 
surgery. The operative procedure included midline lapa-
rotomy, high ligation of the inferior mesenteric vessels, 
mobilization of the splenic flexure, colorectal resection 
with TME, and a double stapled coloanal anastomosis. 
All the patients had negative distal and circumferential 
margins on subsequent histological examination.
LARS scale (Table 1)
The LARS score consists of five items concerning the 
following: incontinence for flatus, incontinence for 
liquid stool, frequency of bowel movements, clustering 
of stools, and urgency. Each symptom of bowel dysfunc-
tion is weighed according to its impact on the quality 
of life. The calculated score ranges from 0 to 42, with 
a score of 0–20 representing no ARS, a score of 21–29 
representing minor ARS, and a score of 30–42 repre-
senting major ARS. 
Statistical analysis
The results were analysed using the SPSS 17.0 statisti-
cal package (Chicago, IL). Data are described in terms 
of absolute and relative frequencies in percentages and 
averages with standard deviation for continual variables, 
or the median and interquartile range if the data distri-
bution made this advisable. Firstly possible risk factors 
with the LARS category were analysed in univariate 
analysis. This had the purpose of identifying statistically 
significant variables using the Student t-test (Mann–
Whitney U test) or Pearson’s × 2 (Fisher’s test).
Results
Clinical and demographic data of the patients are shown 
in Table 2. 80 (74.1%) of the patients had cancer in the 
middle third, and 28 patients (25.9%) – in the lower 
third of the rectum. 53 patients (49.1%) underwent 
neoadjuvant radiotherapy.
Table 1. Lithuanian version of Low anterior resection syndro-
me score (LARS-LT) 
1. Ar kada nors yra buvę, kad negalėjote kontroliuoti 
dujų susikaupimo (pagadinote orą)?
 Ne, niekada
 Taip, rečiau negu kartą per savaitę
 Taip, mažų mažiausiai (bent) kartą per savaitę
2. Ar kada nors turėjote atsitiktinį vandeningo išsitušti-
nimo pratekėjimą?
 Ne, niekada
 Taip, rečiau negu kartą per savaitę
 Taip, mažų mažiausiai kartą per savaitę
3. Kaip dažnai tuštinatės?
 Daugiau negu 7 kartus per dieną (24 valandas) (per 
parą)
 4–7 kartus per dieną ( 24 valandas )
 1–3 kartus per dieną (24 valandas)
 Rečiau negu kartą per savaitę (24 valandas )
4. Ar kada nors tuštinotės vėl, nepraėjus valandai po 
paskutinio tuštinimosi?
 Ne, niekada
 Taip, rečiau negu kartą per savaitę.
 Taip, mažų mažiausiai kartą per savaitę
5. Ar kada nors turėjote labai skubų poreikį tuštintis, 
kad privalėjote bėgti į tualetą?
 Ne, niekada
 Taip, rečiau negu kartą per savaitę
 Taip, mažų mažiausiai kartą per savaitę 
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According to our data 27 patients (25%) had no ARS, 
81 (75%) had ARS; of them: 26 (24%) had minor ARS 
and 55 (56%) had major ARS.
In univariate analysis age, sex, neoadjuvant radio-
therapy, and tumour localization did not have an impact 
on severity of bowel dysfunction symptoms after low 
anterior resection with TME. LARS score could not 
Table 2. Clinical and demographic characteristics of 108 patients undergoing low anterior resection for rectal cancer
Variables Absolute number Per cent
Male 69 63.89
Female 39 36.11
Age (years), mean (SD) 66.93 (9.57) na
Stage, TNM
     I 30 27.78
     II 37 34.26
     III 41 37.96
Tumour localization
     Lower third 28 25.93
     Middle third 80 74.07
Neoadjuvant radiotherapy 53 49.07
LARS score, mean (SD) 28.23 (11.03) na
Time after operation (months), mean (SD) 35.2 (15.21; 7 to 65) na
SD = standard deviation; LARS score = Low Anterior Resection Syndrome score
Table 3. Univariate analysis of risk factor for ARS
Risk factor LARS score (mean ± SD) p
Sex
    Male





    <66.5




Distance of tumour from anal verge (cm)
    <10





    No




Length of postoperative period (mo)          
   <12




LARS low anterior resection syndrome, SD standard deviation
detect differences between female and male patient 
groups (p=0.33), patients who had/had not undergone 
radiation therapy (p=0.07), and those with low or high 
tumour edge level (p=0.17). However, there was sig-
nificant difference between patients who filled the scale 
less than 12 month and more than 12 month after the 
operation (Table 3).
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Discussion
With improving surgical techniques of colorectal anas-
tomosis, operations involving removal of rectal tumours 
with adequate surgical margin and mesorectal have 
become the current surgical standard for rectal cancer 
[8]. But restoration of bowel continuity does not always 
mean a good function. Up to 90 % of patients experi-
ence some degree of bowel dysfunction [9].
In our study, more than half of the patients who 
underwent low anterior resection for rectum cancer 
presented with major ARS, and only one-fourth had 
no quantifiable ARS. The overall perception of quality 
of life was significantly worse in patients with a major 
ARS. Only time after surgery (less than one year) was 
significant factor associated with the ARS. Although 
the functional alterations of the ARS are more intense 
and apparent in the first 12 months after surgery, after 
which the symptoms stabilise, the long-term results 
indicate that the ARS is a permanent alteration with 
a multifactor physiopathology. In a recent study by 
Sturiale et al, authors found that ARS is present even in 
patients 10 years and more after rectal resection [10]. 
Another study showed no changes in anorectal function 
between one year and five years after the operation [11]. 
Furthermore, neoadjuvant radiotherapy before surgery 
and TME were not associated with worse functional 
outcomes in our study. This finding is conflicting com-
pared to recent studies on rectal cancer management 
[12, 13]. In a French study investigating the localization 
of rectal tumours, the authors found that an anastomosis 
more distant from the anal verge did not improve the 
quality of the life of patients [14]. This corresponds 
with our findings. In addition, our study did not show 
any influence on age or sex for ARS. However, in one 
study the sex and a younger age were shown as factors 
worsening ARS [15].  
The limitations of this study are related to its retro-
spective nature and the fact that patients underwent rec-
tal resection and TME, later followed by the takedown 
of the ileostomy over a 5 year period of time, and were 
then questioned in 2014 after a very different time lapse 
following initial surgery. Secondly, we introduced only 
108 patients – small study size.
Conclusion
To conclude, more than half of the patients operated 
for cancer of the rectum by anterior resection present 
an ARS quantified as ‘‘major’’ on the LARS scale, which 
affects their quality of life. Time after the procedure is 
the most important independent risk factor for a major 
ARS. The LARS scale is a simple and quick means of 
quantifying the ARS and comparing the functional re-
sults of different therapeutic or reconstructive strategies 
following rectal resection. It may also be useful in evalu-
ating the duration of the efcacy of different treatments 
which have the aim of relieving or improving the ARS.
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